Ligand-triggered resistance to molecular targeted drugs in lung cancer: Roles of hepatocyte growth factor and epidermal growth factor receptor ligands
2012 ◽
Vol 103
(7)
◽
pp. 1189-1194
◽
2012 ◽
Vol 7
(2)
◽
pp. 272-280
◽
2009 ◽
Vol 16
(1)
◽
pp. 174-183
◽
2012 ◽
2010 ◽
2019 ◽
Vol 15
(4)
◽
pp. 876
2020 ◽
Vol 16
(5)
◽
pp. 1196